Loading HEPA…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("HEPA","financials")Full statements spill as a table. For one cell: =jivedata("HEPA","Revenue") or =jivedata("HEPA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
HEPA • CIK 0001583771
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $0 | — | — | $0 |
| Operating Income (Loss) | $-48,447.954 | $-19,346.578 | $-4,163.691 | $-3,147.585 |
| Weighted Average Number of Shares Outstanding, Basic | 3,970,810 | 122,894 | 9,409,375 | 16,179,218 |
| Research and Development Expense | $35,639.656 | $11,847.348 | $445.512 | $120.918 |
| General and Administrative Expense | $9,618.298 | $7,499.23 | $3,315.433 | $3,026.667 |
| Goodwill and Intangible Asset Impairment | $3,190 | $3,190 | $402.746 | $402.746 |
| Operating Expenses | $48,447.954 | $19,346.578 | $4,163.691 | $3,147.585 |
| Interest Income (Expense), Nonoperating, Net | — | $-1,247.313 | $-24.406 | $-0.347 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-49,335.064 | $-16,161.672 | $-8,277.85 | $-8,277.85 |
| Income Tax Expense (Benefit) | $-409.022 | $-2,969.252 | $-2,969.252 | $-2,969.252 |
| Net Income (Loss) Attributable to Parent | $-48,926.042 | $-13,192.42 | $-8,277.85 | $-3,188.419 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Assets | $18,094.397 | $1,613.737 | $3,069.952 | $1,927.442 |
| Derivative Liability, Noncurrent | $3,796.39 | $333.189 | $103.022 | $156.164 |
| Liabilities | $10,813.59 | $3,477.075 | $402.405 | $648.923 |
| Cash | $14,785.88 | $406.408 | $1,828.062 | $1,628.625 |
| Prepaid Expense, Current | $2,701.96 | $1,207.329 | $1,241.89 | $298.817 |
| Assets, Current | $17,487.84 | $1,613.737 | $3,069.952 | $1,927.442 |
| Accounts Payable, Current | $2,348.829 | $220.202 | $167.81 | $169.875 |
| Accrued Liabilities, Current | $2,439.351 | $23.684 | $77.507 | $322.884 |
| Notes Payable, Current | — | $2,900 | $54.066 | $54.066 |
| Liabilities, Current | $5,290.096 | $3,143.886 | $299.383 | $492.759 |
| Common Stock, Value, Issued | $0.482 | $0.014 | $1.162 | $2.912 |
| Additional Paid in Capital | — | $234,252.981 | $247,060.568 | $247,728.818 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-78.779 | $8.345 | $8.345 | $8.345 |
| Retained Earnings (Accumulated Deficit) | $-224,627.386 | $-237,819.806 | $-246,097.656 | $-248,156.684 |
| Stockholders' Equity Attributable to Parent | $7,280.807 | $-1,863.338 | $2,667.547 | $1,278.519 |
| Common Stock, Shares Authorized | 120,000,000 | 120,000,000 | 120,000,000 | 120,000,000 |
| Common Stock, Shares, Issued | 4,818,733 | 139,168 | 11,620,317 | 29,120,317 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-48,926.042 | $-13,192.42 | $-8,277.85 | $-3,188.419 |
| Net Cash Provided by (Used in) Operating Activities | $-40,888.878 | $-18,216.303 | $-3,271.52 | $-1,594.109 |
| Payments to Acquire Investments | — | — | $132.117 | $132.117 |
| Payments to Fund Long-term Loans to Related Parties | — | $600 | $600 | $600 |
| Net Cash Provided by (Used in) Investing Activities | $-14.304 | $-600 | $-132.117 | $-132.117 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $5.024 | $87.124 | $87.124 | $87.124 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-36,403.208 | $-14,379.472 | $1,421.654 | $-1,295.77 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $14,785.88 | $406.408 | $1,828.062 | $-155.747 |
| Share-based Payment Arrangement, Noncash Expense | $1,340.311 | $791.645 | $20.783 | $20.783 |
| Asset Impairment Charges | — | — | $402.746 | $402.746 |
| Depreciation, Depletion and Amortization | $67.131 | $30.758 | $30.758 | $30.758 |
| Amortization of Debt Discount (Premium) | — | $1,268.817 | $1,268.817 | $1,268.817 |
| Fair Value Adjustment of Warrants | $1,317.646 | $-5,579.263 | $4,089.753 | $40.487 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $-440 | $-2,020 | $-2,020 | $-2,020 |
| Proceeds from Issuance of Common Stock | $4,494.95 | $2,500 | $9,000 | $700 |
| Payments of Stock Issuance Costs | — | — | $802.597 | $30 |
| Proceeds from Other Equity | — | — | $2,500 | — |
| Repayments of Notes Payable | — | — | $3,372.112 | $371.661 |
| Net Cash Provided by (Used in) Financing Activities | $4,494.95 | $4,349.707 | $4,825.291 | $298.339 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $0 | — | $17.765 | $17.765 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $302.919 | $-4,545.565 | $1.431 | $271.566 |
| IncreaseDecreaseInOperatingLeaseLiability | $-96.712 | $-209.02 | $-209.02 | $-209.02 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $-2,675.066 | $-1,858.823 | $-491.617 | $-1,282.257 |